Virion X
@virionx.bsky.social
At Virion X, our mission is to make critical virological research for epidemiology, vaccine development and antiviral discovery accessible to everyone by harnessing the rapid adaptability of viral pseudotypes.
Pinned
Virion X
@virionx.bsky.social
· Mar 14
🚨 We Want to Hear from You! 🚨Please take a moment to complete our quick 5-question survey. It will only take a minute, but your input will help shape the future of our work.
👉https://virion-dde96pr8.scoreapp.com
#Virology #Research #VirionX #PseudotypedVirus #Pseudotyping #biotech
👉https://virion-dde96pr8.scoreapp.com
#Virology #Research #VirionX #PseudotypedVirus #Pseudotyping #biotech
Reposted by Virion X
The GamEvac-Combi Ebola vaccine, which employs rVSV and rAd5 vectors in a heterologous prime-boost format, was found to be safe and immunogenic in healthy adults in a phase 1-2 clinical clinical trial.
www.frontiersin.org/journals/imm...
#Virology #Vaccine #ClinicalTrials #EbolaVaccine
www.frontiersin.org/journals/imm...
#Virology #Vaccine #ClinicalTrials #EbolaVaccine
Frontiers | Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia
www.frontiersin.org
April 17, 2025 at 12:51 PM
The GamEvac-Combi Ebola vaccine, which employs rVSV and rAd5 vectors in a heterologous prime-boost format, was found to be safe and immunogenic in healthy adults in a phase 1-2 clinical clinical trial.
www.frontiersin.org/journals/imm...
#Virology #Vaccine #ClinicalTrials #EbolaVaccine
www.frontiersin.org/journals/imm...
#Virology #Vaccine #ClinicalTrials #EbolaVaccine
🚨 We Want to Hear from You! 🚨Please take a moment to complete our quick 5-question survey. It will only take a minute, but your input will help shape the future of our work.
👉https://virion-dde96pr8.scoreapp.com
#Virology #Research #VirionX #PseudotypedVirus #Pseudotyping #biotech
👉https://virion-dde96pr8.scoreapp.com
#Virology #Research #VirionX #PseudotypedVirus #Pseudotyping #biotech
March 14, 2025 at 3:54 PM
🚨 We Want to Hear from You! 🚨Please take a moment to complete our quick 5-question survey. It will only take a minute, but your input will help shape the future of our work.
👉https://virion-dde96pr8.scoreapp.com
#Virology #Research #VirionX #PseudotypedVirus #Pseudotyping #biotech
👉https://virion-dde96pr8.scoreapp.com
#Virology #Research #VirionX #PseudotypedVirus #Pseudotyping #biotech
🚀 Exciting news! We’re launching Virion X, a biotech dedicated to making critical virology research more accessible. We’re building a waitlist so you’ll be the first to know when we go live. lnkd.in/emSCjXcY
#VirionX #Virology #Pseudotyping #Biotech #startup #pseudotypedvirus
#VirionX #Virology #Pseudotyping #Biotech #startup #pseudotypedvirus
February 27, 2025 at 9:33 AM
🚀 Exciting news! We’re launching Virion X, a biotech dedicated to making critical virology research more accessible. We’re building a waitlist so you’ll be the first to know when we go live. lnkd.in/emSCjXcY
#VirionX #Virology #Pseudotyping #Biotech #startup #pseudotypedvirus
#VirionX #Virology #Pseudotyping #Biotech #startup #pseudotypedvirus